Diagnosing and treating osteoporosis in practice
The aim of osteoporosis treatment is prevention of fractures
Dr John Carey, Rheumatology Consultant, Rheumatology Department, Galway University Hospital, Galway and Dr Orla Ni Mhuircheartaigh, Senior House Officer, Rheumatology Department, Galway University Hospital, Galway
March 1, 2012
- Article
- Similar articles
-
Osteoporosis is the most common disease of the skeleton, resulting in compromised bone strength and a subsequent increased risk of fractures.1 The prevalence is rising as longevity increases. Current estimates suggest that approximately 300,000 Irish citizens have osteoporosis, a figure expected to double over the next 20 years.2 This condition is commonly seen in primary care3 where it can usually be diagnosed and managed successfully. Fractures are the most important clinical manifestation of osteoporosis, which can have significant morbidity, increased mortality and costs the state nearly e400 million annually. Fractures are preventable by diagnosing osteoporosis before a fracture occurs, or identifying those who are at risk, and instituting effective preventative measures.
Pathogenesis
Bone strength reflects its composition, mass and structure. Bone mineral density (BMD) is responsible for 70% of bone strength,4 while the remaining 30% relates to the organisation of these minerals along with the distribution of other bone components such as the protein content.5 BMD is 70-80% genetic; the remainder depends on lifestyle choices, diseases and medications.6
Peak bone mass is achieved in early adulthood, depending on the skeletal site and individual. Later bone loss occurs at different sites and rates, most notably at the spine and hips. With normal life expectancy, women lose 40-50% of their bone mass and men 30-40% during the remainder of their lives.6 Genes and hormonal factors have a large influence on bone health, but nutrition, lifestyle, illness and medications are also key determinants of this process.7-9
Risk factors
Risk factors for osteoporosis can be divided into modifiable and non-modifiable. While both are important for identifying the population or individuals at risk, modifiable risk factors have the potential to be rectified, optimising management.
Non-modifiable risk factors:
-
Genetics: up to 80 different genes have been identified as affecting BMD.10 Limited insights have been gained to date on the importance of each on skeletal fragility
-
Gender: women account for almost three times the number of osteoporotic fractures as men. This is because men have greater bone acquisition during puberty, reduced bone loss, and probably most importantly, males do not experience menopause or oestrogen loss11
-
Age: Bone loss occurs with ageing. The older the population, the higher the risk of fracture12
-
Ethnicity: Rates of osteoporosis are higher in Asian and European populations, but these figures are less durable when adjusted for variations in body size.13
Modifiable risk factors
Numerous modifiable risk factors exist, related to the supply of nutrients to bone, and stimulation of skeletal processes.
-
Exercise: Activity levels during childhood play an important role in the laying down of bone. Muscles attached to bone act as a stimulus for the osteoblasts to produce bone. Weight-bearing forces help arrange bone in a manner capable of resisting impact. Bone is dynamic and decreased activity levels consequently increase bone resorption8
-
Nutrition: A healthy balanced diet is essential for skeletal growth and homeostasis. Deficiencies, particularly of protein, calcium and vitamin D result in impaired skeletal composition and defective repair.8,9
A growing list of diseases and medications are known to affect bone (see Table 1).8,9,14,15 While the exact pathobiologic pathways may vary, the net result is impaired bone strength, decreased balance and muscle strength, with consequent increase in fracture risk.
Table 1(click to enlarge)
Diagnosis
Osteoporosis can be diagnosed in three ways: by the presence of a fragility fracture; by bone densitometry of the hip, spine and occasionally radius; or by histomorphometric analysis of a tetracycline-labelled bone biopsy. The latter is seldom used, so only the first two will be discussed here.16
A fragility fracture is a fracture that occurs following, or in the absence of, low impact trauma. Healthy adult bone should be able to withstand the impact from a fall from a standing position, and fractures occurring from forces below this threshold are considered fragility fractures.
In severe osteoporosis, minimum movements such as coughing or laughing, or a slip and fall, can induce a fragility fracture. The most commonly affected sights include the vertebrae (45%), hip (20%) and wrist and forearm (18%). Fragility fractures are diagnosed based on careful history, examination and radiological evidence of a fracture. Only one-third of vertebral fractures present with pain, so doctors need to be mindful of this when assessing older patients. Suggestive physical examination features include height loss (> 2 inches), kyphosis and increasing abdominal protuberance. A DXA scan is not always necessary to diagnose osteoporosis in this setting. It is recommended along with other investigations as part of a baseline and appropriate assessment, but should not delay the institution of therapy.
Other tests, including biochemistries such as calcium, vitamin D, alkaline phosphate, phosphate, albumin and creatinine, should be undertaken in all individuals prior to treatment, and additional bloods as clinically indicated, eg. coeliac serology. Advances in DXA technology have enabled patients to obtain a ‘lateral vertebral assessment’ scan option at the time of scanning in appropriate circumstances. Such tests can identify vertebral compression fractures in at-risk individuals, which are asymptomatic in 70% of patients.17
In 1994 the World Health Organization (WHO) defined postmenopausal osteoporosis based on central DXA measurement of the proximal femur.17 Central DXA diagnostic criteria have been modified over the years to allow a diagnosis of osteoporosis to be made in men aged 50 years and older, at the spine, hip and occasional distal radius using T-scores18:
-
Normal BMD: T-score ≥ -1.0
-
Low bone mass or osteopaenia: T-score -1.01 to -2.49
-
Osteoporosis: T-score -2.5 or less.
Anybody with prevalent fragility fractures and a T-scores ≤ -2.5 are usually classified as having severe osteoporosis.
DXA criteria for all others (men < 50 years of age, premenopausal women and children) are based on DXA Z-scores. A Z-score of less than -2.0 is considered ‘low BMD for age’ and a diagnosis of osteoporosis should not be made using DXA alone in these populations.18
All diagnostic tests are imperfect and lack specificity and sensitivity. DXA scanning alone may be insufficient to diagnose osteoporosis so it is important to assess a patient’s clinical context and risk factors along with the BMD results. Various fracture risk assessment tools have been available for some time. Because fractures are multifactorial, because people with multiple risk factors for fracture have a greater propensity to fracture than people with a single risk factor including low BMD, and because many patients fracture though they do not have osteoporosis by DXA criteria, such clinical tools are very appealing. The development of clinical risk prediction tools is a complex and arduous process and fracture risk prediction tools are no different. Several are available online,21 including the WHO FRAX tool.20, 21 While it appears to incorporate multiple risk factors, in reality, age and DXA account for the bulk of the tool’s prediction power.20 Unfortunately, the external validity of these tools (how well they work in other populations, or in practice) has been poor to date, and none has robust validation for the Irish population. Further refinements will increase their value and clinical utility.18
Management
The aim of treatment is fracture prevention. Healthy lifestyle choices are crucial, including regular weight-bearing exercise, cessation of smoking, avoiding excess alcohol use and a diet rich in calcium and vitamin D.3,8,14,15,22-25 Very low body weight is a risk factor for fracture in both men and women and recent evidence now clearly shows that obesity is a risk factor for fracture in men.19 Optimal calcium and vitamin D intake are important and while dietary intake is preferable, supplements are safe and effective if required. The recommended daily allowance of elemental calcium is 1,000-1,500mg per day and 600-800 international units for vitamin D. Supplementation should be considered in patients where dietary intake is poor, or in persons with malabsorption (eg. cystic fibrosis, coeliac disease, prior bowel removal). A calcium intake questionnaire is ideal to ascertain whether supplements are necessary.3,23,25
Treating the underlying disease is critical in secondary osteoporosis and when possible, medications deleterious to bone such as corticosteroids should be avoided or reduced. Switching diuretics like furosemide to thiazides reduces renal calcium wasting. More recently, multiple studies have shown that long-term proton-pump inhibitor use is associated with increased risk of fractures. Fall prevention programmes by a trained physiotherapist are helpful and reduction of unnecessary medication use has also been shown to reduce falls.3,22,23,25
Table 2(click to enlarge)
